Pharma Journalist -

Industry experts are set to discuss on the latest developments in the field of Drug Discovery Chemistry at the 3rd Annual Drug Discovery Chemistry Conference 2019, taking place in…
Read More...

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company signed a license agreement with Daewoong Pharmaceutical…
Read More...

Teva Pharmaceutical Industries Ltd. announced positive topline results from the Phase IIIb FOCUS study that evaluated the efficacy and safety of fremanezumab for the preventive…
Read More...

DelSiTech Ltd and Innovare R&D have signed a world-wide, exclusive licence agreement for the use of DelSiTech’s Silica Matrix drug delivery platform in the development and…
Read More...

AstraZeneca announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has now received formal marketing authorisation from the National…
Read More...

Selexis SA and Teneobio, Inc. announced that they have entered into a second services agreement to expand Teneobio’s oncology pipeline of Human Heavy-Chain Antibodies (UniAbs™), a new…
Read More...

Proteostasis Therapeutics, a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other…
Read More...

Nicox SA and Ocumension Therapeutics announced that they have entered into an exclusive license agreement for the development and commercialization of Nicox’s product candidate, NCX…
Read More...

SMi Group’s next annual Adaptive Designs in Clinical Trials conference is thrilled to welcome Sandeep Menon, Vice President and Head of Early Clinical Development at Pfizer Inc. onto…
Read More...

SMi Reports: Chief Scientific Officer of MiNA Therapeutics set to speak at RNA Therapeutics 2019, following MiNA Therapeutics’ successful liver cancer therapy news. The field of RNA…
Read More...